Molecular pathogenesis of Merkel cell carcinoma
$444,785ZIAFY2011CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 34208349Paper 34193920Paper 33800889Paper 32753470Paper 31218705Paper 30541782Paper 30287935Paper 29721394Paper 28340681Paper 28130073Paper 27262710Paper 26299616Paper 26022453Paper 25521454Paper 23652945
Abstract
To identify genetic alterations present in Merkel cell carcinoma, we have conducted molecular analyses of human tumors across multiple genome-wide platforms to assay gene expression, identify gene mutations and characterize chromosomal alterations. These date are presently being analyzed to identify key driver alterations for this tumor. We have also begun to generate mice where oncogenic modifications are carried out in specific skin lineages in an attempt to transform Merkel cells in vivo. Finally we have begun work generating new cell lines for Merkel cell carcinoma and are conducting a genetic knock-down screen to identify druggable pathways important for tumor survival.
View original record on NIH RePORTER →